Reeves could find herself with even more headroom if she makes some subtle changes to how government debt is measured. One rumoured option would be to introduce a new ‘public sector net worth’ (PSNW) ...

Stay true to your investing philosophy. Our large-cap screens give a spread of ideas for a portfolio of UK-listed income shares. When judging the small-cap and Aim-listed results, however, the ...

Chinese stocks were up a bit on Monday after more details about stimulus efforts. The finance ministry pledged to “significantly increase” debt to boost the economy but declined to say by how much.

Our reader has competing aims for their cash windfall and needs help finding the right way to invest. Dave Baxter takes a look ...

After a quiet few years as property values adjusted to higher interest rates, Reits have raised £2.3bn over the course of ...

RBC economists said at the end of September that “growth in the second half of this year is likely to turn out significantly weaker than both we and the ECB had been expecting up to very recently”.

Dan Jones is joined by the IC team to unpack strategies to make the best returns, confectionery stocks and Boeing’s results ...

The potential escalation in the Middle East, and its impact on energy prices, drove up valuations for both BP (BP.) and Shell (SHEL), even though the latter oil & gas major recently announced a cut in ...

Geographic diversification is a staple of all good portfolios. But you can attain it in many ways, from buying one or two global funds to using a different fund for each region. Or you can invest in ...

It’s safe to assume that shareholders will approve his elevation to executive chair at the company’s annual general meeting in December and, if they do, he will be replaced as chief executive by ...

Shareholders of asset manager Schroders (SDR) will sympathise with this dilemma after a torrid couple of years. Punishing market conditions and a misfiring acquisitions policy have brought the share ...

Lawyers representing 10 groups of plaintiffs, or 80,000 liability cases across the US, have backed the payout. There remain another few thousand cases not covered by the payout. GSK will also pay a ...